Intervention not reported
Subjective impact of fatigue on ADL, fatigue severity (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Hypertension (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in hypertension (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Nausea (adverse effect, post‐intervention) · people with Parkinson's disease
It is very uncertain whether the intervention changes nausea (adverse effect, post‐intervention) (very low certainty).
1 finding from 1 review
Intervention not reported
Orthostatic hypotension (adverse effect, post‐intervention) · people with Parkinson's disease
It is very uncertain whether the intervention changes orthostatic hypotension (adverse effect, post‐intervention) (very low certainty).
1 finding from 1 review
Intervention not reported
HRQOL (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Subjective impact of fatigue on ADL, fatigue severity (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
HRQOL (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Nausea (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention leads to higher nausea (adverse effect, post‐intervention) (high certainty).
1 finding from 1 review
Intervention not reported
Subjective impact of fatigue on ADL, fatigue severity (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Anxiety (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in anxiety (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Hypertension (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in hypertension (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Impulse control disorders (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in impulse control disorders (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
UPDRS III UPDRS scale (motor score). Scale from: 0 to 56. · people with Parkinson's disease
1 finding from 1 review
UPDRS ADL score · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Reduction in salivary flow
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Reduction in frequency and severity of drooling
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Adverse Effects to BoNT‐A
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Non‐compliance with intervention
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Reduction in salivary flow
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Reduction in frequency and severity of drooling
1 finding from 1 review
no estimate extracted
Studies not reported
Low